0JJM Stock Overview
An in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BioPorto A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.1.22 |
| 52 Week High | kr.2.63 |
| 52 Week Low | kr.1.22 |
| Beta | 1.18 |
| 1 Month Change | -3.49% |
| 3 Month Change | -42.23% |
| 1 Year Change | n/a |
| 3 Year Change | -72.24% |
| 5 Year Change | n/a |
| Change since IPO | -59.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0JJM | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.9% | 0.5% |
| 1Y | n/a | -20.4% | 6.3% |
Return vs Industry: Insufficient data to determine how 0JJM performed against the UK Biotechs industry.
Return vs Market: Insufficient data to determine how 0JJM performed against the UK Market.
Price Volatility
| 0JJM volatility | |
|---|---|
| 0JJM Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 7.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0JJM's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0JJM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1917 | 27 | n/a | bioporto.com |
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.
BioPorto A/S Fundamentals Summary
| 0JJM fundamental statistics | |
|---|---|
| Market cap | kr.683.38m |
| Earnings (TTM) | -kr.53.82m |
| Revenue (TTM) | kr.32.38m |
20.8x
P/S Ratio-12.5x
P/E RatioIs 0JJM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0JJM income statement (TTM) | |
|---|---|
| Revenue | kr.32.38m |
| Cost of Revenue | kr.10.33m |
| Gross Profit | kr.22.04m |
| Other Expenses | kr.75.87m |
| Earnings | -kr.53.82m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 01, 2024
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 68.08% |
| Net Profit Margin | -166.23% |
| Debt/Equity Ratio | 0% |
How did 0JJM perform over the long term?
See historical performance and comparison